Seattle, April 28, 2020 – Malaria No More applauds the bipartisan congressional effort, led by Reps. Barbara Lee (D-CA) and Martha Roby (R-AL), calling for $1 billion in emergency funding for the Global Fund to Fight AIDS, Tuberculosis, and Malaria’s COVID-19 Response Mechanism, to be included in future COVID-19-related supplemental funding. This allocation would provide emergency support to countries to address COVID-19, while at the same time, protect the progress made against malaria, AIDS and TB. The letter, sent to House Leadership, was signed by 105 Members of Congress.

The COVID-19 pandemic is challenging ongoing efforts and disrupting essential services in the fight against existing epidemics, including malaria, AIDS and TB. According to a recent modeling analysis released by the World Health Organization and partners, severe disruptions to insecticide-treated net campaigns and in access to antimalarial medicines could lead to a doubling in the number of malaria deaths in sub-Saharan Africa this year compared to 2018. Countries are being urged to do their utmost to quickly and safely maintain these essential malaria control services.

Every year, U.S. global health investments in the Global Fund to Fight AIDS, Tuberculosis and Malaria save millions of lives, protect the world’s most vulnerable from disease, and build strong health systems. During an unprecedented global health crisis, U.S. leadership and these continued investments are critical.

Read the letter below or view the PDF version here.


For more information, contact Taylor Prochnow at +1 206-605-4090 or Taylor.Prochnow@MalariaNoMore.org.

About Malaria No More

Malaria No More envisions a world where no one dies from a mosquito bite. More than a decade into our mission, our work has contributed to historic progress toward this goal. Now, we’re mobilizing the political commitment, funding, and innovation required to achieve what would be one of the greatest humanitarian accomplishments – ending malaria within our generation. For more information, visit www.malarianomore.org

April 27, 2020

The Honorable Nancy Pelosi
Speaker, U.S. House of Representatives H-232, The Capitol
Washington, D.C. 20515

The Honorable Kevin McCarthy Republican Leader
H-204, The Capitol Washington, D.C. 20515

CC: Chairwoman Nita Lowey

Ranking Member Kay Granger

Dear Speaker Pelosi and Leader McCarthy,

We write in support of a U.S. contribution of $1 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria’s COVID-19 Response Mechanism as part of future COVID-19- related supplemental funding. This allocation would provide emergency support to countries to address COVID-19 and protect fragile gains in the response to AIDS, TB and malaria.

COVID-19 represents an existential threat to ongoing efforts against the epidemics of AIDS, TB, malaria. The Global Fund has already taken several steps to mitigate the damage. On March 4 the Global Fund announced that it was making $500 million available to implementing countries for crucial COVID-19 response activities. On April 9, the Global Fund’s Board unanimously approved an additional $500 million in existing funding for the new COVID-19 Response Mechanism to help countries fight COVID-19 and mitigate its impact on health systems, particularly AIDS, TB, and malaria programs.

The ultimate amount of external funding needed to help developing countries cope with COVID- 19 and mitigate its harm to health systems is unknown; however, the UN currently estimates that an additional $500 billion is needed for emergency health services and related programs. Additionally, a group of 165 leaders and experts wrote an April 6 letter to the G-20 citing the need for $35 billion to support countries with weaker health systems and especially vulnerable populations, plus an immediate $8 billion need to fill gaps in COVID-19 response capacity based on the estimate of the Global Preparedness Monitoring Board.

The Global Fund has enjoyed broad bipartisan support from both the House of Representatives and our colleagues in the Senate. This support has been maintained because the Global Fund has consistently demonstrated concrete progress in saving lives. The Global Fund’s primary advantage is that it can rapidly deliver funding to existing local partners in over 100 countries – with all of the same accountability and transparency it has shown in disbursing roughly $4 billion per year in grant funding. The organization has deep experience in funding the infrastructure and capabilities needed to defeat COVID-19: medical supply chains, laboratories, community health workers, and disease surveillance.

U.S. investment at a time like this does more than fight disease – it helps keep Americans safe. Health security knows no borders and pandemics can bounce back on U.S. citizens. As COVID-

19 spreads to developing countries, it threatens to derail years of progress fighting HIV, TB, and malaria by disrupting essential prevention and treatment services and interrupting supply chains for critical drugs and medical supplies. Experience from recent Ebola outbreaks in Africa has shown that unless mitigating action is taken, the additional death toll from AIDS, TB, and malaria could well exceed the number of deaths from COVID-19 itself. COVID-19 is on a trajectory to overwhelm communities and health systems in developing countries with potentially catastrophic consequences.

Because of its results-oriented, efficient and transparent approach, the Global Fund has received high marks in multilateral aid reviews. Independent watchdogs with the highest standards, including the Multilateral Organization Performance Assessment Network (MOPAN), agree. The U.S. government served as the institutional lead for MOPAN’s recent assessment, which commended the Global Fund for its clear strategic direction, risk management, transparency, accountability, and “low operational budget.” The Global Fund has a strong, independent Inspector General office that reports directly to the Global Fund board and has effective whistleblower and audit functions.

The Global Fund and the U.S. bilateral programs have worked diligently to increasingly integrate their planning and programming over the years. PEPFAR, PMI, and USAID have come to depend on the Global Fund as a trusted partner in saving lives and strengthening health systems.

Our investment in the Global Fund’s COVID-19 Resource Mechanism will no doubt motivate other donors to contribute, just as our commitments in fiscal year 2020 encouraged countries to come forth with strong pledges for the 6th Replenishment.

Importantly, with the establishment of the COVID-19 Response Mechanism the Global Fund is not straying from its core mandate. Indeed, if it does not address the grave challenge presented by COVID-19, the Global Fund, its donors, and their partners risk losing the progress they have fought so hard to achieve.

The U.S. has shown unparalleled leadership in global health. We urge you to maintain that leadership, to set an example for the world, and to invest in defeating COVID-19 and AIDS, TB, and malaria through the Global Fund’s COVID-19 Response Mechanism.


Barbara Lee, Member of Congress

Martha Roby, Member of Congress

Karen Bass, Member of Congress

Ro Khanna, Member of Congress

Andy Levin, Member of Congress

Tom Malinowski, Member of Congress

Vicente Gonzalez, Member of Congress

Gerald E. Connolly, Member of Congress

Adam Smith, Member of Congress

Will Hurd, Member of Congress

Jerry McNerney, Member of Congress

Jim Himes, Member of Congress

Ann Wagner, Member of Congress

Chris Stewart, Member of Congress

Chrissy Houlahan, Member of Congress

Sylvia R. Garcia, Member of Congress

Joe Neguse, Member of Congress

Christopher H. Smith, Member of Congress

Gregory W. Meeks, Member of Congress

Donna E. Shalala, Member of Congress

Derek Kilmer, Member of Congress

Donald S. Beyer, Jr., Member of Congress

Donald M. Payne, Jr., Member of Congress

Eleanor Holmes Norton, Member of Congress

James P. McGovern, Member of Congress

Jim Costa, Member of Congress

Lloyd Doggett, Member of Congress

Brian Fitzpatrick, Member of Congress

David B. McKinley, P.E., Member of Congress

Bonnie Watson Coleman, Member of Congress

Suzan DelBene, Member of Congress

Jackie Speier, Member of Congress

Daniel T. Kildee, Member of Congress

Tom Cole, Member of Congress

Brenda L. Lawrence, Member of Congress

Richard E. Neal, Member of Congress

Mike Doyle, Member of Congress

Jahana Hayes, Member of Congress

Don Young, Member of Congress

André Carson, Member of Congress

Robin L. Kelly, Member of Congress

Eddie Bernice Johnson, Member of Congress

Judy Chu, Member of Congress

Mark Pocan, Member of Congress

Jimmy Panetta, Member of Congress

Gilbert R. Cisneros, Jr., Member of Congress

Peter A. DeFazio, Member of Congress

C.A. Dutch Ruppersberger, Member of Congress

Sheila Jackson Lee, Member of Congress

Denny Heck, Member of Congress

Pramila Jayapal, Member of Congress

David Trone, Member of Congress

Rosa L. DeLauro, Member of Congress

Ed Case, Member of Congress

Danny K. Davis, Member of Congress

Colin Z. Allred, Member of Congress

Wm. Lacy Clay, Member of Congress

Grace Meng, Member of Congress

Katie Porter, Member of Congress

Earl Blumenauer, Member of Congress

Harley Rouda, Member of Congress

David E. Price, Member of Congress

Rashida Tlaib, Member of Congress

Ted Deutch, Member of Congress

Jamie Raskin, Member of Congress

Joaquin Castro, Member of Congress

Rick Larsen, Member of Congress

Betty McCollum, Member of Congress

Chuck Fleischmann, Member of Congress

Anthony G. Brown, Member of Congress

Lisa Blunt Rochester, Member of Congress

John Yarmuth, Member of Congress

Bobby L. Rush, Member of Congress

Adriano Espaillat, Member of Congress

John P. Sarbanes, Member of Congress

Ted W. Lieu, Member of Congress

Suzanne Bonamici, Member of Congress

William R. Timmons, IV, Member of Congress

Anna G. Eshoo, Member of Congress

Debbie Mucarsel-Powell, Member of Congress

Bill Foster, Member of Congress

Deb Haaland, Member of Congress

Maxine Waters, Member of Congress

William R. Keating, Member of Congress

Henry C. "Hank" Johnson, Jr., Member of Congress

Mark Takano, Member of Congress

Dave Loebsack, Member of Congress

Alma S. Adams, Ph.D., Member of Congress

Debbie Dingell, Member of Congress

Al Green, Member of Congress

Linda T. Sánchez, Member of Congress

Zoe Lofgren, Member of Congress

TJ Cox, Member of Congress

Jennifer Wexton, Member of Congress

Rob Woodall, Member of Congress

Chellie Pingree, Member of Congress

Darren Soto, Member of Congress

Susan W. Brooks, Member of Congress

Stephanie Murphy, Member of Congress

Lizzie Fletcher, Member of Congress

Bill Flores, Member of Congress

Mary Gay Scanlon, Member of Congress

Mike Levin, Member of Congress

Nydia M. Velazquez, Member of Congress

Ami Bera, M.D., Member of Congress

Copyright 2017 © by Malaria No More All rights Reserved.
Malaria No More is a 501(c)(3) nonprofit. EIN 20-5664575